Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations

ALKin Lung Cancer: Past, Present, and Future

(2013) Alice T. Shaw et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

(2013) Neal I. Lindeman et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

MET and EGFR Mutations Identified in ALK-Rearranged Pulmonary Adenocarcinoma: Molecular Analysis of 25 ALK-Positive Cases

(2013) Jennifer M. Boland et al.   Journal of Thoracic Oncology

Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinomas: Relationship with CT Characteristics and Histologic Subtypes

(2013) Hyun-Ju Lee et al.   RADIOLOGY

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Crizotinib in the treatment of non-small-cell lung cancer

(2012) Patrick M Forde et al.   EXPERT OPINION ON PHARMACOTHERAPY

Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene

(2012) Takayuki Fukui et al.   LUNG CANCER

Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation

(2012) June Koo Lee et al.   LUNG CANCER

Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas

(2011) Akihiko Yoshida et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Pyrosequencing, a method approved to detect the two major EGFR mutations for anti EGFR therapy in NSCLC

(2011) Sandrine Dufort et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Comparison of thin-section CT and pathological findings in small solid-density type pulmonary adenocarcinoma: Prognostic factors from CT findings

(2010) Mizuki Ikehara et al.   EUROPEAN JOURNAL OF RADIOLOGY

Are There Imaging Characteristics Associated with Epidermal Growth Factor Receptor and KRAS Mutations in Patients with Adenocarcinoma of the Lung with Bronchioloalveolar Features?

(2010) Catherine Glynn et al.   Journal of Thoracic Oncology

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

(2010) Makoto Maemondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

(2010) Eunice L. Kwak et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene

(2009) Tsuyoshi Takahashi et al.   ANNALS OF SURGICAL ONCOLOGY

TheEML4-ALKfusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-typeEGFRandKRAS

(2009) Daisy Wing-Sze Wong et al.   CANCER

Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population

(2009) S. J. Rodig et al.   CLINICAL CANCER RESEARCH

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE

EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers

(2008) Kentaro Inamura et al.   Journal of Thoracic Oncology

Gefitinib in Advanced Non-Small Cell Lung Cancer: Does It Deserve a Second Chance?

(2008) T. E. Stinchcombe et al.   ONCOLOGIST

Radiological-pathological correlation in intratumoural tissue components of solid lung tumours

(2008) E. Quaia et al.   Radiologia Medica

Fleischner Society: Glossary of Terms for Thoracic Imaging

(2008) David M. Hansell et al.   RADIOLOGY